Please select a country and, if applicable, a language.

Samodzielne stosowanie leków jest ważnym filarem opieki zdrowotnej

… i, tak jak w przypadku terapii zaleconej przez lekarza, powinno być oparte na dostępnych dowodach naukowych. Evidence for Self-Medication (EfSM) prezentuje zwięzłe streszczenia istotnych badań dotyczących leków i substancji czynnych dostępnych bez recepty, aby umożliwić aptekarzom i osobom wykonującym inne zawody związane z ochroną zdrowia udzielanie możliwie jak najlepszych – i opartych na dowodach – porad dotyczących samodzielnego stosowania leków. 


Wszystkie artykuły opublikowane na stronie EfSM zostały zrecenzowane. Są dostępne w języku niemieckim i angielskim, a wiele z nich również w innych językach.

Real-world data confirm effectiveness of a thyme-ivy extract combination

From October 2019 to April 2020, the phytopharmaceutical Bronchipret® Drops, which contains a thyme-ivy extract combination (BNO 1200), was investigated in a large, practice-oriented, pharmacy-based observational study. The results show that the OTC drug quickly and sustainably alleviates bronchitis symptoms as well as severity of coughing, and reduces coughing bouts during the day and cough-assoc ...

Do artykułu
Autor: Claudia B. BittnerEFSM: 2023;3:230009DOI: 10.52778/efsm.23.0009Data: 29.01.2023

Efficacy and safety of fexofenadine in children with allergic rhinitis

Allergic rhinitis is the most common undiagnosed chronic condition in children and negatively affects sleep, school performance and leisure activities. Intranasal corticosteroids and oral antihistamines are first-line treatments. The first generation of oral antihistamines is often used in children due to the cheaper costs, despite the high frequency of adverse events, like overall cognitive and p ...

Do artykułu
Autor: Margarita Murrieta-Aguttes, MD, Mohamed Amessou, PhD, MBA i Michele Lheritier-Barrand, MDEFSM: 2023;3:230003DOI: 10.52778/efsm.23.0003Data: 29.01.2023

Onychomycosis guideline update

Self-medication with antimycotic nail polishes plays an important role in Germany due to the numerous OTC drugs available and an increasing number of onychomycosis cases. Older patients in particular are more frequently affected due to slower nail growth and the possible existence of predisposing diseases [1]. But the prevalence is also increasing in children [2]. This makes guideline-based recomm ...

Do artykułu
Autor: Prof. Dr. med. Peter Mayser i Mareike NiehausEFSM: 2023;3:230001DOI: 10.52778/efsm.23.0001Data: 02.01.2023

Onset of the neutralising action of antacids based on calcium and magnesium carbonate using an …

An in-vitro study

The in-vitro study evaluated the onset of the neutralising action of the antacid Rennie® as compared to a placebo. Among other things, the results showed a rise in the pH of the artificial stomach liquid from pH 1 to over 3 within 40 seconds after application of the antacid. The maximum pH of 5.24 was maintained over a period of approximately 10 minutes. At the same time, lower activity levels of ...

Do artykułu
Autor: Sandra Bartylla i Malte GrieswelleEFSM: 2022;2:220160DOI: 10.52778/efsm.22.0160Data: 14.12.2022

Metamizole: A comprehensive approach to its benefit-risk profile

Metamizole is a drug with many years of use in some countries, and a large number of patients are exposed to its pharmacologic effects. The safety assessments have been done decades ago; therefore, it is worth summarizing the current state of knowledge of its benefit-risk profile.

Do artykułu
Autor: Waltraud Stromer, PhD i Mariana Palladini, PhDEFSM: 2022;2:220153DOI: 10.52778/efsm.22.0153Data: 02.11.2022

Newsletter EfSM

Nasz newsletter dostarcza  informacji o najnowszych publikacjach EfSM.

Zarejestruj się tutaj

Wyróżniony artykuł

Fexofenadine in children with allergic rhinitis

Oral antihistamines are first-line treatments for children with allergic rhinitis. A recent review evaluated second-generation antihistamines in comparison to first-generation antihistamines.

Do artykułu